<DOC>
	<DOCNO>NCT02985619</DOCNO>
	<brief_summary>Background : Diabetic macular edema ( DME ) show sustain functional morphologic response anti-vascular endothelial growth factor ( VEGF ) drug , optimal approach persistent macular edema still debate . Purpose : To evaluate 24-week visual anatomical effect intravitreal bevacizumabe triamcinolone patient residual edema 24-weeks `` pro nata '' ( prn ) intravitreal bevacizumabe therapy . Methods : This study enrol total 100 DME eye . Each patient receive `` prn '' bevacizumabe therapy throughout 24 week . At week 24 , patient recurrent persistent edema randomize 1:1 Group 1 ( prn bevacizumane ) Group 2 ( prn triamcinolone ) . Patients recurrent persistent edema week 24 comprise Group 3 continue receive prn bevacizumabe . Prn treatment administer central subfield thickness macula ( CST ) &gt; 300 µm and/or intraretinal cystoid space fovea . Study visit occur every 4 week endpoint week 48 . At visit , patient eye exam CST , best-corrected visual acuity ( BCVA ) , intraocular pressure ( IOP ) assess . Fundus photography fluorescein angiography also perform baseline , week 16 , week 40 , week 48 . Rescue therapy use laser photocoagulation could administer discretion Investigators . All patient resume standard care exit .</brief_summary>
	<brief_title>Bevacizumabe Triamcinolone Persistent Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Diabetic macular edema &gt; 300µm central subfield macular thickness OCT ; Best correct vision acuity minimum : 20/32 20/320 ; Vitreomacular traction ; Macular ischemia ; Laser injection therapy 3 month assign protocol.\ Pregnancy ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>